Showing results (61-70 of 113) with videos related to
Sort By:
Pageof 12
Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2012
Sustained efficacy and safety of raltegravir after 5 years of combination antiretroviral therapy as initial treatment of HIV-1 infection: final results of a randomized, controlled, phase II study (Protocol 004)Eduardo Gotuzzo, Martin Markowitz, Winai Ratanasuwan, et al.Journal of Virology|September 13, 2003
Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapyMichael A Poles, Shady Barsoum, Wenjie Yu, et al.The Journal of Infectious Diseases|March 28, 2003
Determining the relative efficacy of highly active antiretroviral therapyMichael Louie, Christine Hogan, Michele Di Mascio, et al.Plos Medicine|December 7, 2006
Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infectionSaurabh Mehandru, Michael A Poles, Klara Tenner-Racz, et al.The Journal of Infectious Diseases|August 14, 2016
Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug UseMartin Markowitz, Sherry Deren, Charles Cleland, et al.Journal of Virology|October 27, 2006
Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infectionSaurabh Mehandru, Michael A Poles, Klara Tenner-Racz, et al.The Lancet. Infectious Diseases|June 9, 2014
Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week results of a randomised, open-label, phase 3b non-inferiority trialAnton Pozniak, Martin Markowitz, Anthony Mills, et al.Journal of Virology|August 10, 2007
Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infectionSaurabh Mehandru, Brigitta Vcelar, Terri Wrin, et al.The Journal of Infectious Diseases|July 28, 2011
Identifying the early post-HIV antibody seroconversion periodFrederick M Hecht, Robert Wellman, Michael P Busch, et al.AIDS (London, England)|December 1, 2016
Cabotegravir long acting injection protects macaques against intravenous challenge with SIVmac251Chasity D Andrews, Leslie St Bernard, Amanda Yee Poon, et al.Pageof 12